InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,842.65
(
0.47%
)
US TECH 100
19,646.80
(
0.07%
)
Dow Jones
43,079.82
(
0.79%
)
Brent Oil
74.13
(
-0.46%
)
Bitcoin
67,764.61
(
1.13%
)
Post# of 346493
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

itsabouttime

Send PM Follow Ignore
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

itsabouttime

Re: md1225 post# 216994

Saturday, 04/25/2015 5:48:56 PM

Saturday, April 25, 2015 5:48:56 PM

Post# of 346493
Approval will assure great combo treatments.


Please note I believe the PD-1 class of drugs to be an essential part of the cure for cancer and as a practitioner want expanded label ASAP. Bavituximab will make PD-1 non responders into responders. A perfect one two punch.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM

SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM

Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM

Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM

One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM

ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM

Start posting your company's news
Only $200 per official company press release!